Align Technology Inc., a global leader in medical devices, announced its financial results for the second quarter of 2025. The company reported total revenues of $1,012.4 million, reflecting a 3.4% increase from the previous quarter but a 1.6% decrease compared to the same period last year. Clear Aligner revenues for Q2'25 amounted to $804.6 million, which is a 1.0% sequential increase but a 3.3% decline year-over-year. In contrast, revenues from Imaging Systems and CAD/CAM Services rose by 13.9% sequentially and 5.6% year-over-year, totaling $207.8 million. The company's Q2'25 net income stood at $124.6 million, with a diluted net income per share of $1.72. On a non-GAAP basis, net income was $181.1 million, and diluted net income per share was $2.49. The operating income for the second quarter was $163.0 million, with an operating margin of 16.1%. The non-GAAP operating margin was reported at 21.3%. Align Technology's cash and cash equivalents increased to $901.2 million from $873.0 million at the end of the first quarter of 2025. Despite mixed results, the company noted strong consumer interest in Invisalign® treatment, though there was a slight decline in Clear Aligner revenues due to lower-than-expected volumes in Europe and North America. Looking ahead, Align Technology expects a decline in Q3'25 Systems and Services revenues due to seasonal factors. The company anticipates a worldwide GAAP gross margin of 64% to 65%, down approximately 5 to 6 points sequentially due to one-time charges estimated at $45 to $55 million. These charges are primarily expected for asset write-downs, accelerated depreciation expense, and restructuring. The GAAP operating margin is projected to decrease to between 10.5% and 11.5%, also influenced by anticipated one-time charges of $50 to $60 million.